| 000 | 01650 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516073725.0 | ||
| 264 | 0 | _c20120718 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1480-3275 | ||
| 024 | 7 |
_a10.1139/w11-115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Feijun | |
| 245 | 0 | 0 |
_aProtective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2. _h[electronic resource] |
| 260 |
_bCanadian journal of microbiology _cFeb 2012 |
||
| 300 |
_a117-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-2 _xchemistry |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aSyphilis _xmetabolism |
| 650 | 0 | 4 |
_aTreponema pallidum _xgenetics |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 700 | 1 | _aWang, Shiping | |
| 700 | 1 | _aZhang, Xiaohong | |
| 700 | 1 | _aGu, Weiming | |
| 700 | 1 | _aYu, Jian | |
| 700 | 1 | _aLiu, Shuangquan | |
| 700 | 1 | _aZeng, Tiebing | |
| 700 | 1 | _aZhang, Yuejun | |
| 700 | 1 | _aWu, Yimou | |
| 773 | 0 |
_tCanadian journal of microbiology _gvol. 58 _gno. 2 _gp. 117-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1139/w11-115 _zAvailable from publisher's website |
| 999 |
_c21475388 _d21475388 |
||